Infection Clinical Trial
Official title:
Vaginal Fluid (VF) Test VF-Testâ„¢ for Prediction of Extremely Preterm Birth After Exam-Indicated Cerclage Protocol for Prospective, Multicenter, Cohort Clinical Trial
The purpose of this research study is to determine if a vaginal fluid (VF) test can predict
very early preterm birth in patients who are scheduled to have an exam indicated cerclage for
severe cervical shortening.
Prior to participants undergoing a scheduled amniocentesis two swabs to collect vaginal
secretions for the VF tests will be done. During the amniocentesis your doctor will remove
amniotic fluid as part of the routine clinical care. From that fluid sample, the study will
use less than a quarter teaspoon for the amniotic fluid study test (AF test). Data regarding
maternal and birth outcomes will be collected by medical record review.
The purpose of this research study is to determine if a vaginal fluid (VF) test can predict
very early preterm birth in patients who are scheduled to have an exam indicated cerclage for
severe cervical shortening.
Prior to participants undergoing a scheduled amniocentesis, an ultrasound will be done to
confirm cervical length and dilation. During a separate sterile speculum exam, the physician
will use two swabs to collect vaginal secretions for the VF test. During the amniocentesis
the doctor will remove approximately 2 teaspoon of amniotic fluid as part of your standard
clinical care. From that fluid sample, the study will use less than a quarter teaspoon for a
amniotic fluid study test (AF test). Data regarding maternal and birth outcomes will be
collected by medical record review.
The vaginal fluid (VF) sample collection will take approximately 15 minutes to do. The total
time in the study is about seven and a half months (from the time the patient consents until
4 weeks after delivery). The only study procedure the patient will experience during her
study participation is the collection of the vaginal fluid specimens.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |